Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,171 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

EUS-CPN With and Without Bupivacaine

for
Pancreatic Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04951804

Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for
Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer,
Location: Montreal, Boston MA, Providence RI, Toronto, London,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05797168

Phase1, Phase2, Recruiting

Effects of Individualized Cognitive Training on Cognition in Heart Failure

for
Heart Failure
Location: Montreal
Sponsor: Louis Bherer

Sex: All

Age: 50+

Code: NCT05223426

Recruiting

Cannabis as a Complementary Treatment in Multiple Sclerosis

for
Multiple Sclerosis
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 21+

Code: NCT05092191

Phase2, Recruiting

Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates

for
Kidney Disease, End-Stage, Frailty, Transplant;Failure,Kidney
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06089473

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Methionine Intake Microbiota

for
Healthy
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 20 - 50

Code: NCT07283328

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Montreal, Ottawa, Quebec, Toronto, The Bronx NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase3, Recruiting

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

for
Sepsis, Acute Kidney Injury
Location: Montreal, Quebec, Levis, Boston MA, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07215702

Phase2, Recruiting

Reducing Systemic Inflammation in People on Antiretroviral Therapy

for
Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT07030920

Phase2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Montreal, Sherbrooke, East Syracuse NY, Hartford CT,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

for
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Location: Montreal, Etobicoke, Toronto, Hamilton, Edmonton,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07160608

Phase2, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Montreal, Saint-Jerôme, Quebec, Chicoutimi, Oshawa,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase3, Recruiting

A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism

for
Primary Hyperaldosteronism
Location: Montreal, Ottawa, Toronto, Chicago IL, Columbia SC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07007793

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Montreal, Quebec, New Haven CT, Barrie, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

for
Venous Thromboembolism
Location: Montreal, Ottawa, Windsor
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06440694

Phase3, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Montreal, New York NY, Newark DE, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Montreal, Greenfield Park, Saint-Hubert, Terrebonne,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

for
PSC
Location: Montreal, Boston MA, New Haven CT, Toronto, Richmond VA,
Sponsor: PSC Partners Seeking a Cure

Sex: All

Age: 18 - 70+

Code: NCT06297993

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Montreal, Trois-Rivieres, Levis, Chicoutimi, Boston MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Montreal, Saint-Jerôme, Kingston, South Portland ME,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting